APA (7th ed.) Citation

Patel, J. N., Jiang, C., Owzar, K., Mulkey, F., Luzum, J. A., Mamon, H. J., . . . McLeod, H. L. (2021). Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance). Pharmacogenetics and genomics, 31(9), 215. https://doi.org/10.1097/FPC.0000000000000442

Chicago Style (17th ed.) Citation

Patel, Jai N., et al. "Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/leucovorin or Epirubicin/cisplatin/fluorouracil Before and After Chemoradiation on CALGB 80101 (Alliance)." Pharmacogenetics and Genomics 31, no. 9 (2021): 215. https://doi.org/10.1097/FPC.0000000000000442.

MLA (9th ed.) Citation

Patel, Jai N., et al. "Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/leucovorin or Epirubicin/cisplatin/fluorouracil Before and After Chemoradiation on CALGB 80101 (Alliance)." Pharmacogenetics and Genomics, vol. 31, no. 9, 2021, p. 215, https://doi.org/10.1097/FPC.0000000000000442.